ovalbumin-pulsed, CD40-silenced dendritic cells (University of Western Ontario)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameovalbumin-pulsed, CD40-silenced dendritic cells (University of Western Ontario)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Western Ontario

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Western Ontario

Active IndicationsN/A

Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A